DK1692158T3 - VEGF-binding og understøttede peptider til behandling af hudsygdomme - Google Patents

VEGF-binding og understøttede peptider til behandling af hudsygdomme

Info

Publication number
DK1692158T3
DK1692158T3 DK04810431.9T DK04810431T DK1692158T3 DK 1692158 T3 DK1692158 T3 DK 1692158T3 DK 04810431 T DK04810431 T DK 04810431T DK 1692158 T3 DK1692158 T3 DK 1692158T3
Authority
DK
Denmark
Prior art keywords
peptides
treatment
supported
skin diseases
vegf binding
Prior art date
Application number
DK04810431.9T
Other languages
English (en)
Inventor
Anthony G Day
David A Estell
Christopher J Murray
Scott D Power
Original Assignee
Danisco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco Us Inc filed Critical Danisco Us Inc
Application granted granted Critical
Publication of DK1692158T3 publication Critical patent/DK1692158T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
DK04810431.9T 2003-11-06 2004-11-06 VEGF-binding og understøttede peptider til behandling af hudsygdomme DK1692158T3 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US51815403P 2003-11-06 2003-11-06
US52040303P 2003-11-13 2003-11-13
US53120703P 2003-12-19 2003-12-19
US53095403P 2003-12-19 2003-12-19
US53118903P 2003-12-19 2003-12-19
PCT/US2004/036976 WO2005046709A2 (en) 2003-11-06 2004-11-06 Tgf - beta binding and supported peptides

Publications (1)

Publication Number Publication Date
DK1692158T3 true DK1692158T3 (da) 2012-02-06

Family

ID=34596198

Family Applications (2)

Application Number Title Priority Date Filing Date
DK04810431.9T DK1692158T3 (da) 2003-11-06 2004-11-06 VEGF-binding og understøttede peptider til behandling af hudsygdomme
DK04800809.8T DK1680507T3 (da) 2003-11-06 2004-11-06 Bakterieekspression af proteaseinhibitorer og varianter deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK04800809.8T DK1680507T3 (da) 2003-11-06 2004-11-06 Bakterieekspression af proteaseinhibitorer og varianter deraf

Country Status (9)

Country Link
US (8) US20080113917A1 (da)
EP (4) EP1692159B1 (da)
JP (2) JP4843497B2 (da)
AT (4) ATE486087T1 (da)
CA (1) CA2544820C (da)
DE (2) DE602004029812D1 (da)
DK (2) DK1692158T3 (da)
ES (1) ES2375360T3 (da)
WO (4) WO2005046709A2 (da)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1692159B1 (en) * 2003-11-06 2010-09-29 Danisco US Inc. Tgf-beta1 binding and supported peptides
CN1875029B (zh) * 2003-11-06 2010-06-16 金克克国际有限公司 蛋白酶抑制剂及其变异体在丝状真菌中的表达
ATE536552T1 (de) * 2004-10-15 2011-12-15 Danisco Us Inc Kompetitven differential screening
US9084734B2 (en) * 2005-05-05 2015-07-21 Danisco Us Inc. Peptide personal care compositions and methods for their use
CA2610976C (en) * 2005-06-10 2020-11-24 Robbie Woodman Use of stefin a as a scaffold protein
AU2006268111A1 (en) * 2005-07-13 2007-01-18 Amgen Mountain View Inc. Il-6 binding proteins
GB0601684D0 (en) * 2006-01-27 2006-03-08 Reckitt Benckiser Uk Ltd Composition, process for preparation and method of use
WO2007092465A2 (en) * 2006-02-07 2007-08-16 Dyao Pharmaceutical Corporation Topical delivery compositions
AU2007296186B2 (en) * 2006-09-16 2014-01-23 Soy Labs Llc Products and methods using soy peptides to lower total and LDL cholesterol levels
US20080124355A1 (en) 2006-09-22 2008-05-29 David Gordon Bermudes Live bacterial vaccines for viral infection prophylaxis or treatment
US20080090745A1 (en) * 2006-10-13 2008-04-17 Fox Bryan P Expression of Streptomyces subtilism inhibitor (SSI) proteins in Bacillus and Streptomyces sp.
WO2008076322A2 (en) * 2006-12-18 2008-06-26 Danisco Us, Inc., Genencor Division Novel laccases, compositions and methods of use
KR20090101193A (ko) * 2006-12-21 2009-09-24 다니스코 유에스 인크. 바실러스 종 １９５ 의 알파-아밀라아제 폴리펩티드에 대한 조성물 및 용도
US20100233780A1 (en) * 2007-06-06 2010-09-16 Wolfgang Aehle Methods for Improving Protein Properties
US20090048136A1 (en) * 2007-08-15 2009-02-19 Mcdonald Hugh C Kappa-carrageenase and kappa-carrageenase-containing compositions
EP2229439A1 (en) * 2007-10-31 2010-09-22 Danisco US Inc. Use and production of neutral metallproteases in a serine protease-free background
US20090221030A1 (en) * 2007-11-01 2009-09-03 Kai Bao Signal sequences and co-expressed chaperones for improving protein production in a host cell
GB0722332D0 (en) * 2007-11-14 2007-12-27 Reckitt Benckiser Uk Ltd Personal care article
KR20100108413A (ko) * 2008-01-29 2010-10-06 다니스코 유에스 인크. 바실러스 및 스트렙토마이세스 종 내 스트렙토마이세스 서브틸리신 억제제 (ｓｓｉ) 단백질의 발현
KR20100109945A (ko) 2008-02-04 2010-10-11 다니스코 유에스 인크. 변경된 특성을 지닌 ｔｓ23 알파-아밀라아제 변이체
WO2010044786A1 (en) 2008-10-15 2010-04-22 Danisco Us Inc., Genencor Division Modified variant bowman birk protease inhibitors
US7803902B2 (en) 2008-10-15 2010-09-28 Danisco Us Inc. Modified variant bowman birk protease inhibitors
US7772181B2 (en) * 2008-10-15 2010-08-10 Danisco Us Inc. Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors
US8241623B1 (en) 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
CN102341495A (zh) 2009-03-10 2012-02-01 丹尼斯科美国公司 巨大芽孢杆菌菌株DSM90相关的α-淀粉酶及其使用方法
US20100247693A1 (en) * 2009-03-24 2010-09-30 Marini Jan L Cosmetic formulation to treat rosacea telangiectasia
EP2417254B1 (en) 2009-04-08 2014-05-21 Danisco US Inc. Halomonas strain wdg195-related alpha-amylases, and methods of use, thereof
DK2421973T3 (da) 2009-04-24 2018-07-30 Danisco Us Inc Proteaser med modificerede pro-områder
MX2011011619A (es) * 2009-05-01 2012-02-28 Signal Invest And Man Co Composicion antimicrobiana hidratante.
AR076941A1 (es) 2009-06-11 2011-07-20 Danisco Us Inc Cepa de bacillus para una mayor produccion de proteina
US20110052676A1 (en) * 2009-09-01 2011-03-03 James Vincent Gruber Composition For Delaying Cellular Senescence
WO2011034940A1 (en) 2009-09-15 2011-03-24 Five Prime Therapeutics, Inc. Hair growth methods using fgfr4 extracellular domains
GB0921001D0 (en) * 2009-11-30 2010-01-13 Aqua Bio Technology Asa Products and uses
CN102762222B (zh) 2009-12-09 2015-11-25 丹尼斯科美国公司 包含蛋白酶变体的组合物和方法
US8685931B2 (en) 2009-12-17 2014-04-01 Five Prime Therapeutics, Inc. Hair growth methods using FGFR3 extracellular domains
BR112012016232A2 (pt) * 2009-12-30 2017-03-07 Solae Llc processo para separação e purificação de um produto de kti
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US9687591B2 (en) 2010-03-31 2017-06-27 Agency For Science, Technology And Research Building stratified biomimetic tissues and organs using crosslinked ultrashort peptide hydrogel membranes
US8999916B2 (en) 2010-03-31 2015-04-07 Agency For Science, Technology And Research Crosslinked peptide hydrogels
KR101895245B1 (ko) * 2010-03-31 2018-09-05 에이전시 포 사이언스, 테크놀로지 앤드 리서치 양친매성 선형 펩티드/펩토이드 및 이를 포함하는 히드로겔
US20110281327A1 (en) 2010-04-15 2011-11-17 Danisco Us Inc. Compositions And Methods Comprising Variant Proteases
BR112012028466B1 (pt) 2010-05-06 2020-03-17 The Procter & Gamble Company Composição de produtos com variantes de protease e método para tratar e/ou limpar uma superfície
US8481038B2 (en) 2010-11-15 2013-07-09 Five Prime Therapeutics, Inc. Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins
EP2705145B1 (en) 2011-05-05 2020-06-17 The Procter and Gamble Company Compositions and methods comprising serine protease variants
EP2705146B1 (en) 2011-05-05 2018-11-07 Danisco US Inc. Compositions and methods comprising serine protease variants
EP2751263A1 (en) 2011-08-31 2014-07-09 Danisco US Inc. Compositions and methods comprising a lipolytic enzyme variant
CN104024407A (zh) 2011-12-22 2014-09-03 丹尼斯科美国公司 包含脂解酶变体的组合物和方法
US9120841B2 (en) 2012-09-28 2015-09-01 Agency For Science, Technology And Research Amphiphilic linear peptidepeptoid and hydrogel comprising the same
KR20150067336A (ko) 2012-10-12 2015-06-17 다니스코 유에스 인크. 지방분해 효소 변이체를 포함하는 조성물 및 방법
MX2015005577A (es) 2012-11-05 2015-07-23 Danisco Inc Composiciones y metodos que comprenden variantes de proteasa termolisina.
EP2935573A1 (en) 2012-12-19 2015-10-28 Danisco US Inc. Novel mannanase, compositions and methods of use thereof
US9593339B1 (en) 2013-02-14 2017-03-14 David Gordon Bermudes Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
JP2016526880A (ja) 2013-05-29 2016-09-08 ダニスコ・ユーエス・インク 新規メタロプロテアーゼ
WO2014194032A1 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
JP6367930B2 (ja) 2013-05-29 2018-08-01 ダニスコ・ユーエス・インク 新規メタロプロテアーゼ
US20160108388A1 (en) 2013-05-29 2016-04-21 Danisco Us Inc. Novel metalloproteases
ES2797483T3 (es) 2013-07-19 2020-12-02 Danisco Us Inc Composiciones y métodos comprendiendo una variante de enzima lipolítica
EP3044313B1 (en) 2013-09-12 2019-11-06 Danisco US Inc. Compositions and methods comprising lg12-clade protease variants
RU2016117978A (ru) * 2013-10-11 2017-11-17 Дженентек, Инк. Ингибиторы nsp4 и способы их применения
JP2016535770A (ja) 2013-11-01 2016-11-17 スフェリウム バイオメッド エス．エル． 治療用及び美容用物質を経皮送達するための封入体
DK3080262T3 (da) 2013-12-13 2019-05-06 Danisco Us Inc Serinproteaser af bacillus-arter
EP3910057A1 (en) 2013-12-13 2021-11-17 Danisco US Inc. Serine proteases of the bacillus gibsonii-clade
US9737592B1 (en) * 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
EP4155398A1 (en) 2014-03-21 2023-03-29 Danisco US Inc. Serine proteases of bacillus species
DK3207129T3 (da) 2014-10-17 2020-02-24 Danisco Us Inc Serinproteaser af bacillus-arten
EP3212781B1 (en) 2014-10-27 2019-09-18 Danisco US Inc. Serine proteases
WO2016069557A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases of bacillus species
EP3212783B1 (en) 2014-10-27 2024-06-26 Danisco US Inc. Serine proteases
EP3212662B1 (en) 2014-10-27 2020-04-08 Danisco US Inc. Serine proteases
EP3550017B1 (en) 2014-10-27 2021-07-14 Danisco US Inc. Serine proteases
US20180216090A1 (en) 2015-03-12 2018-08-02 Danisco Us Inc. Compositions and methods comprising lg12-clade protease variants
WO2016183509A1 (en) 2015-05-13 2016-11-17 Danisco Us Inc. AprL-CLADE PROTEASE VARIANTS AND USES THEREOF
EP4234693A3 (en) 2015-06-17 2023-11-01 Danisco US Inc Bacillus gibsonii-clade serine proteases
WO2016205710A1 (en) 2015-06-17 2016-12-22 Danisco Us Inc. Proteases with modified propeptide regions
CN107022432A (zh) * 2016-01-29 2017-08-08 高露洁-棕榄公司 清洁组合物
EP3845642B1 (en) 2016-05-05 2023-08-09 Danisco US Inc. Protease variants and uses thereof
WO2017210295A1 (en) 2016-05-31 2017-12-07 Danisco Us Inc. Protease variants and uses thereof
CN109563497A (zh) 2016-06-17 2019-04-02 丹尼斯科美国公司 蛋白酶变体及其用途
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN110312795A (zh) 2016-12-21 2019-10-08 丹尼斯科美国公司 蛋白酶变体及其用途
CN110312794B (zh) 2016-12-21 2024-04-12 丹尼斯科美国公司 吉氏芽孢杆菌进化枝丝氨酸蛋白酶
US11298391B1 (en) * 2017-04-27 2022-04-12 Lorenol Laboratories, Inc. Topical skin health improvement compositions and administrations thereof
CN111373039A (zh) 2017-11-29 2020-07-03 丹尼斯科美国公司 具有改善的稳定性的枯草杆菌蛋白酶变体
EP3799601A1 (en) 2018-06-19 2021-04-07 Danisco US Inc. Subtilisin variants
WO2019245704A1 (en) 2018-06-19 2019-12-26 Danisco Us Inc Subtilisin variants
WO2020046613A1 (en) 2018-08-30 2020-03-05 Danisco Us Inc Compositions comprising a lipolytic enzyme variant and methods of use thereof
WO2020088393A1 (zh) * 2018-10-31 2020-05-07 青岛蔚蓝生物集团有限公司 一种生产具有蛋白酶抗性的洗涤用酶的方法
US20230028935A1 (en) 2018-11-28 2023-01-26 Danisco Us Inc Subtilisin variants having improved stability
US20220220419A1 (en) 2019-05-24 2022-07-14 Danisco Us Inc Subtilisin variants and methods of use
CN112062828B (zh) * 2019-06-10 2022-04-29 温州医科大学 Fgf-5多肽抑制剂及其生发应用
WO2021146255A1 (en) 2020-01-13 2021-07-22 Danisco Us Inc Compositions comprising a lipolytic enzyme variant and methods of use thereof
US20240034960A1 (en) 2020-08-27 2024-02-01 Danisco Us Inc Enzymes and enzyme compositions for cleaning
CN113307857B (zh) * 2021-01-14 2022-11-01 艾时斌 从表皮生长因子、凝集素和Tat蛋白衍生的支架蛋白
EP4363565A1 (en) 2021-06-30 2024-05-08 Danisco US Inc. Variant lipases and uses thereof
WO2023034486A2 (en) 2021-09-03 2023-03-09 Danisco Us Inc. Laundry compositions for cleaning
CA3240638A1 (en) 2021-12-16 2023-06-22 Michelle Jackson Fabric and home care composition comprising a protease
WO2023114939A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023114936A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
CA3240641A1 (en) 2021-12-16 2023-06-22 Michelle Jackson Automatic dishwashing composition comprising a protease
WO2023114932A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Subtilisin variants and methods of use
WO2023168234A1 (en) 2022-03-01 2023-09-07 Danisco Us Inc. Enzymes and enzyme compositions for cleaning
WO2024050346A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Detergent compositions and methods related thereto
WO2024050343A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Subtilisin variants and methods related thereto
WO2024102698A1 (en) 2022-11-09 2024-05-16 Danisco Us Inc. Subtilisin variants and methods of use

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) * 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US3929678A (en) * 1974-08-01 1975-12-30 Procter & Gamble Detergent composition having enhanced particulate soil removal performance
JPS51125468A (en) * 1975-03-27 1976-11-01 Sanyo Chem Ind Ltd Method of preparing resins of high water absorbency
US4152416A (en) * 1976-09-17 1979-05-01 Marra Dorothea C Aerosol antiperspirant compositions delivering astringent salt with low mistiness and dustiness
US4421769A (en) * 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
FI69503C (fi) * 1984-03-13 1986-02-10 Neste Oy Ytbelagd bergsbehaollare eller tunnel
US5411873A (en) * 1984-05-29 1995-05-02 Genencor, Inc. Process for producing heterologous polypeptides
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5679543A (en) * 1985-08-29 1997-10-21 Genencor International, Inc. DNA sequences, vectors and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi
US4999186A (en) * 1986-06-27 1991-03-12 The Procter & Gamble Company Novel sunscreen agents, sunscreen compositions and methods for preventing sunburn
US4937370A (en) * 1987-06-02 1990-06-26 The Procter & Gamble Company Novel chromophores, sunscreen compositions and methods for preventing sunburn
US5322770A (en) * 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
WO1988002025A1 (en) * 1986-09-17 1988-03-24 Sri International Expression vectors for bacilli
US5087372A (en) * 1989-03-24 1992-02-11 Asahi Kasei Kogyo Kabushiki Kaisha Method for removing heavy metal ions from contaminated water and a porous membrane usable therefor
US5011681A (en) * 1989-10-11 1991-04-30 Richardson-Vicks, Inc. Facial cleansing compositions
US5073371A (en) * 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5073372A (en) * 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5436228A (en) * 1990-12-12 1995-07-25 Postlethwaite; Arnold E. Chemotactic wound healing peptides
US5429950A (en) * 1992-03-30 1995-07-04 Genencor International, Inc. Heterologous gene expression in bacillus subtilis: fusion approach
GB9415421D0 (en) 1994-07-30 1994-09-21 Procter & Gamble Cosmetic compositions and processes for manufacture thereof
ATE178203T1 (de) 1994-11-28 1999-04-15 Procter & Gamble Topische hautpflegemittel enthaltend verdickte polyolestern von carbonsaüren als haut konditionierende agentien
WO1997034005A1 (en) * 1996-03-12 1997-09-18 Genencor International, Inc. Alkaline cellulase and method of producing same
EP0991422A1 (en) * 1996-04-18 2000-04-12 The General Hospital Corporation Modulating epithelial-mesenchymal interactions
US5827508A (en) * 1996-09-27 1998-10-27 The Procter & Gamble Company Stable photoprotective compositions
US5976838A (en) * 1996-12-18 1999-11-02 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CA2272306A1 (en) 1996-11-22 1998-05-28 The Procter & Gamble Company Cosmetic compositions
DE19735587B4 (de) * 1997-08-16 2012-03-22 Eberhard-Karls-Universität Tübingen Universitätsklinikum Peptid mit radioprotektiver Wirkung, dieses enthaltende kosmetische oder pharmazeutische Zusammensetzung, für dieses kodierende Nukleinsäure, Herstellungsverfahren für dieses Peptid und die Verwendung als radioprotektives Agens
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
ATE223971T1 (de) * 1998-07-20 2002-09-15 Inoxell As Neue methoden zum auffinden von liganden- und ziel-biomolekülen
US5989528A (en) 1998-07-30 1999-11-23 The Procter & Gamble Company Sunscreen compositions
US5935556A (en) * 1998-07-30 1999-08-10 The Procter & Gamble Company Sunscreen compositions
JP3855042B2 (ja) * 1998-09-22 2006-12-06 独立行政法人産業技術総合研究所 毛髪の鑑別法
US5972316A (en) * 1998-10-16 1999-10-26 The Procter & Gamble Company UV protection compositions
US5968485A (en) * 1998-10-16 1999-10-19 The Procter & Gamble Company UV protection compositions
AU1275599A (en) 1998-10-23 2000-05-15 Procter & Gamble Company, The Skin care compositions
GB9825854D0 (en) * 1998-11-25 1999-01-20 Univ Bristol Peptide
JP3106191B1 (ja) * 1999-03-30 2000-11-06 工業技術院長 Ｆｇｆ−５の生理的機能制御ペプチド及び該ペプチドを含有する医薬組成物
US7090973B1 (en) * 1999-04-09 2006-08-15 Oscient Pharmaceuticals Corporation Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
US20040031072A1 (en) * 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
US20100293669A2 (en) * 1999-05-06 2010-11-18 Jingdong Liu Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
US6872563B1 (en) * 1999-10-05 2005-03-29 President And Fellows Of Harvard College Compositions and methods for production of disulfide bond containing proteins in host cells
US20020001825A1 (en) * 2000-03-31 2002-01-03 Nobuyuki Itoh Fibroblast growth factor-like molecules and uses thereof
DE60141088D1 (de) * 2000-04-14 2010-03-04 Genencor Int Verfahren zur selektiven zielen
US20110131679A2 (en) * 2000-04-19 2011-06-02 Thomas La Rosa Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
WO2002002621A2 (en) * 2000-06-30 2002-01-10 Zymogenetics, Inc. Mammalian secreted proteins
US6537968B1 (en) * 2000-07-24 2003-03-25 Alphamed Pharmaceuticals Corp Treatment of lupus erythematosus
CA2430953A1 (en) * 2000-12-13 2002-06-20 Borean Pharma A/S Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
US20070020625A1 (en) * 2001-02-07 2007-01-25 Eric Duchaud Sequence of the photorhabdus luminescens strain tt01 genome and uses
BRPI0407399A (pt) * 2003-02-11 2006-02-14 Pasteur Institut molécula, vetor recombinante, polipeptìdeo purificado, anticorpos purificados, célula hospedeira, métodos para produzir um polipeptìdeo, para detectar uma racemase codificada por um suqüência de nucleotìdeos, para tratar uma molécula, para detectar um d-aminoácido e para detectar atividade racemase em um meio de reação, complexo imunológico, kit, composição imunizante, e, plataforma tecnológica e todos os reagentes e dispositivos
EP1692159B1 (en) * 2003-11-06 2010-09-29 Danisco US Inc. Tgf-beta1 binding and supported peptides
CN1875029B (zh) * 2003-11-06 2010-06-16 金克克国际有限公司 蛋白酶抑制剂及其变异体在丝状真菌中的表达
US7319142B1 (en) * 2004-08-31 2008-01-15 Monsanto Technology Llc Nucleotide and amino acid sequences from Xenorhabdus and uses thereof
US7772181B2 (en) * 2008-10-15 2010-08-10 Danisco Us Inc. Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors
US7803902B2 (en) * 2008-10-15 2010-09-28 Danisco Us Inc. Modified variant bowman birk protease inhibitors

Also Published As

Publication number Publication date
EP1680507B1 (en) 2011-06-22
WO2005047314A2 (en) 2005-05-26
DE602004029393D1 (de) 2010-11-11
WO2005046709A2 (en) 2005-05-26
CA2544820A1 (en) 2005-05-26
US20050202535A1 (en) 2005-09-15
US20050238607A1 (en) 2005-10-27
US20080269139A1 (en) 2008-10-30
US20110230405A1 (en) 2011-09-22
WO2005046710A3 (en) 2005-11-24
EP1692158A2 (en) 2006-08-23
US7413877B2 (en) 2008-08-19
EP1692159A2 (en) 2006-08-23
JP2012024091A (ja) 2012-02-09
US20080113917A1 (en) 2008-05-15
WO2005047511A2 (en) 2005-05-26
ES2375360T3 (es) 2012-02-29
WO2005046709A3 (en) 2005-11-24
WO2005047511A3 (en) 2005-11-24
US7485618B2 (en) 2009-02-03
CA2544820C (en) 2014-02-18
JP5728329B2 (ja) 2015-06-03
EP1692158B1 (en) 2011-10-26
EP1692159B1 (en) 2010-09-29
EP1692160A2 (en) 2006-08-23
ATE513917T1 (de) 2011-07-15
US20090111160A1 (en) 2009-04-30
WO2005047314A3 (en) 2006-04-20
JP2008500805A (ja) 2008-01-17
DK1680507T3 (da) 2011-10-10
DE602004029812D1 (de) 2010-12-09
US20050203026A1 (en) 2005-09-15
WO2005046710A2 (en) 2005-05-26
EP1680507A2 (en) 2006-07-19
JP4843497B2 (ja) 2011-12-21
ATE530560T1 (de) 2011-11-15
EP1692160B1 (en) 2010-10-27
ATE482972T1 (de) 2010-10-15
US7524816B2 (en) 2009-04-28
ATE486087T1 (de) 2010-11-15
US7696173B2 (en) 2010-04-13
US20130065829A1 (en) 2013-03-14

Similar Documents

Publication Publication Date Title
DK1692158T3 (da) VEGF-binding og understøttede peptider til behandling af hudsygdomme
EA200701448A1 (ru) Специфически связывающаяся с крипто-антигеном человека молекула (варианты), композиция на ее основе (варианты), способ получения молекулы, способ лечения посредством молекулы (варианты) и способ ингибирования крипто-экспрессии в клетке больного
NO20070908L (no) Sammensmeltede ringheterocykelkinasemodulatorer
EA200801180A1 (ru) Селективные пептидные агонисты рецептора vpac2
WO2006121610A3 (en) Personal care compositions and methods for their use
ATE542920T1 (de) Modifiziertes menschliches wachstumshormon
DK1615952T3 (da) Fremgangsmåder til behandling af betændelsestilstande med specifikke, til humant angiopoietin-2-bindende midler
EA200971077A1 (ru) Гетероциклические модуляторы киназы
ECSP044996A (es) Agentes de contraste de objetivo multimérico basado en péptido
DK1434791T3 (da) Specifikke bindingsmidler til human angiopoietin-2
EA200501771A1 (ru) Лиганды каннабиноидных рецепторов и их применения
EA200700391A1 (ru) Комбинированное лечение с применением слитых белков трансферрина, содержащих glp-1
DE602004029680D1 (de) Isoformen von gehirn-natriuretischem peptid
NO20070950L (no) Preparater og fremgangsmater for anvendelse av angiopoietinlignende-4-protein.
EA200501430A1 (ru) Лиганды каннабиноидных рецепторов и их применение
EA201070888A1 (ru) Антитела и их производные
EA200970403A1 (ru) Бициклические триазолы в качестве модуляторов протеинкиназы
EA201070636A1 (ru) Ингибирование рецептора белка, стимулирующего макрофаги (ron), и способы его лечения
WO2002069900A3 (en) Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors
ATE492563T1 (de) Vollständige humane monoklonale antikörper gegen il-13
ATE504602T1 (de) Für humane matriptase spezifische bindungsproteine
WO2003076592A3 (en) Novel method for delivery and intracellular synthesis of sirna molecules
DK2005185T3 (da) Fremgangsmåde til identifikation af polypeptidtargets
WO2006019982A3 (en) Pin1-modulating compounds and methods of use thereof
CY1111285T1 (el) Θεραπεια αυτοανοσων ασθενειων